GMAB — GENMAB A/S COM

Ownership history in Dorsey Wright & Associates  ·  7 quarters on record

This page tracks every 13F SEC filing in which Dorsey Wright & Associates reported a position in GENMAB A/S COM (GMAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.08% (2022 Q4)
Avg. % of fund
0.71%
First filed
2020 Q2
Last filed
2025 Q4
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 44,837 -42,614 -48.7% 0.30% $1.4M $30.80
2022 Q4 REDUCED 87,451 -18,788 -17.7% 1.08% $3.7M $42.38
2021 Q4 REDUCED 106,239 -4,471 -4.0% 0.87% $4.2M $39.56
2021 Q3 ADDED 110,710 +26,036 +30.7% 1.06% $4.8M $43.70
2020 Q4 REDUCED 84,674 -1,828 -2.1% 0.51% $3.4M $40.66
2020 Q3 ADDED 86,502 +1,167 +1.4% 0.57% $3.2M $36.61
2020 Q2 INITIATED 85,335 — — 0.58% $2.9M $33.89
% of Fund (quarterly)    GMAB price (monthly, adj. close)

Other funds also holding GMAB

As of 2025 Q4 — sorted by position size

Paradigm Biocapital Advisors LP 3Y 5.53% Orbis Allan Gray Ltd 3Y 7Y 1.86% AIMZ Investment Advisors, LLC 3Y 7Y 1.44% Private Wealth Advisors, LLC 3Y 1.3% Terra Nova Asset Management LLC 3Y 7Y 1.23% HARDING LOEVNER LP 3Y 7Y 0.91% Avidity Partners Management LP 3Y 0.82% SUPERSTRING CAPITAL MANAGEMENT LP 0.48% VIRTUS ADVISERS, LLC 3Y 7Y 0.4% Perpetual Ltd 3Y 7Y 0.37%
← Back to Dorsey Wright & Associates Holdings